Sort
48,018 grants matching “immunotherapy”
Negative regulation of myeloid-derived suppressive cells in cancer
$461,819Yulia Nefedova · Wistar Institute · R01 · FY2022 · CA
Role of necroptosis in colorectal cancer therapy
$461,812Lin Zhang · University Of Southern California · R01 · FY2023 · CA
Chimeric Anti CD20 T Cell Receptors for Lymphoma Therapy
$461,767Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
Immune Regulation of Neuronal Injury and Repair
$461,709Kathryn Jane Jones · Indiana University Indianapolis · R01 · FY2017 · NS
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$461,706Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$461,674Chintan Parekh · Children'S Hospital Of Los Angeles · R01 · FY2022 · AI
The Role of EBI3 in Regulating Gastritis and Gastric Carcinogenesis
$461,577Richard J Dipaolo · Saint Louis University · R01 · FY2019 · DK
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
$461,561Rulla M Tamimi · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · CA
Modulation of tumor inflammatory factor for immune therapy
$461,550Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2017 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2022 · CA
Interplay between tumor and microenvironment in bone metastasis
$461,537Paul B Fisher · Virginia Commonwealth University · R01 · FY2023 · CA
MAINLINE HEALTH CCOP
$461,522Lankenau Institute For Medical Research · U10 · FY2004 · CA
An Innovative Immune Therapy with Antibiotics to Treat Deadly Excess Inflammation in Sepsis and ARDS Induced from Severe Bacterial Infection in Geriatric Patients
$461,487Eugene Roussel · Bioprovar Corporation · U44 · FY2025 · AG
Immunoengineering Postdoctoral Training Program - Resubmission - 1
$461,485Melody A Swartz · University Of Chicago · T32 · FY2024 · AI
Further Development of Multi-Antigen, Multi-Peptide Vaccine based on Gene Expression Information to Prevent Triple Negative Breast Cancer in a Mouse Model
$461,468Yian Wang · Medical College Of Wisconsin · N01 · FY2018 · CA
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
$461,446David G Denardo · Washington University · U01 · FY2025 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$461,416Manish Bais · Boston University Medical Campus · R01 · FY2025 · DE
Targeting defective necroptosis in colorectal cancer
$461,400Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Non-Human Primate and Imaging Core
$461,371Francois J Villinger · Northwestern University At Chicago · P01 · FY2021 · AI
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$461,363Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Targeting UHRF1 in combinational immunotherapy
$461,315Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$461,312David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model
$461,312David R Grosshans · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
$461,240Mark S Anderson · University Of California, San Francisco · R01 · FY2025 · DK
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$461,120Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2024 · CA